- Eight start-up companies have been selected to join the latest Oxford AHSN Accelerator programme. They were chosen after successfully pitching their ideas to a panel of industry leaders, investors and senior AHSN staff. Their innovations relate to drug discovery, diagnostics, digital health and service delivery. By the end of November the eight SMEs should have developed a fully formed business venture with the help of experts supporting the programme which is delivered by the Oxford AHSN with BioCity.
The Oxford AHSN Accelerator programme offers a unique launchpad for innovators with an idea they want to bring to market. It guides them on their path to commercialisation, scale-up and impact.
Oxford AHSN Chief Operating Officer Dr Paul Durrands said: “To make a difference to patients’ outcomes, safety and experience we need innovations that are based on real needs and that are evidence based. They also have to be practical and affordable. Our Accelerator helps innovators drill down into customer needs and what will create real value to the NHS.”